ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610173 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610173; 2) Community: the network communities that were significantly associated with the response to NSC 610173; 3) Molecule: the relationships between components within communities and NSC 610173; 4) MDR: the compounds that were significantly associated with the NSC 610173.

NSC Compound Enrichment Correlation
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.00486817664672777 -0.33460573
NSC 742327 (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone 0.00486817664672777 -0.24755652
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.00486817664672777 -0.21367052
NSC 27445 Null 0.00503396694999378 0.25413822
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.00503396694999378 -0.29980243
NSC 329515 Kijanimicin sodium salt 0.00503396694999378 0.12710669
NSC 382054 1H-Benzotriazolium, 6-(2,4-diamino-6-ethyl-5-pyrimidinyl)- 1-hydroxy-2-phenyl-, hydroxide, inner salt 0.00503396694999378 -0.1766997
NSC 6926 Null 0.00503396694999381 -0.13440001
NSC 709974 Null 0.00503396694999381 -0.19811348
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00503396694999381 -0.032500706
Total:111  Current:17    [First] [Prev] [Next] [Last]